ACCELERON PHARMA INC. Financing Cash Flow
ACCELERON PHARMA INC. reported Financing Cash Flow of $20.09 million for the 9-month period ending 2021-09-30, per its 10-Q filed 2021-11-04.
Discontinued › Cash Flow › Financing Activities
us-gaap:NetCashProvidedByUsedInFinancingActivities · last filed 2021-11-04
- ACCELERON PHARMA INC. net cash provided by (used in) financing activities for the quarter ending 2021-09-30 was $14.15M, a 97.18% decline year-over-year.
- ACCELERON PHARMA INC. net cash provided by (used in) financing activities for the quarter ending 2021-06-30 was $2.23M, a 88.20% decline year-over-year.
- ACCELERON PHARMA INC. net cash provided by (used in) financing activities for the quarter ending 2021-03-31 was $3.70M, a 58.32% decline year-over-year.
- ACCELERON PHARMA INC. net cash provided by (used in) financing activities for the quarter ending 2020-12-31 was $9.00M, a 236.59% increase year-over-year.
- ACCELERON PHARMA INC. net cash provided by (used in) financing activities for fiscal 2020 was $538.01M, a 107.95% increase from fiscal 2019.
- ACCELERON PHARMA INC. net cash provided by (used in) financing activities for fiscal 2019 was $258.72M, a 1502.38% increase from fiscal 2018.
- ACCELERON PHARMA INC. net cash provided by (used in) financing activities for fiscal 2018 was $16.15M, a 92.67% decline from fiscal 2017.
- ACCELERON PHARMA INC. net cash provided by (used in) financing activities for fiscal 2017 was $220.30M, a 50.20% increase from fiscal 2016.
| Period end | Net Cash Provided by (Used in) Financing Activities 3 month | Net Cash Provided by (Used in) Financing Activities 6 month | Net Cash Provided by (Used in) Financing Activities 9 month | Net Cash Provided by (Used in) Financing Activities 12 month |
|---|---|---|---|---|
| 2021-09-30 | $14.15M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04 | $16.39M derived: sum of 2 quarters · filed 2021-11-04 | $20.09M 10-Q · filed 2021-11-04 | $29.08M derived: sum of 4 quarters · filed 2021-11-04 |
| 2021-06-30 | $2.23M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-05 | $5.93M 10-Q · filed 2021-08-05 | $14.93M derived: sum of 3 quarters · filed 2021-08-05 | $516.12M derived: sum of 4 quarters · filed 2021-11-04 |
| 2021-03-31 | $3.70M 10-Q · filed 2021-05-06 | $12.70M derived: sum of 2 quarters · filed 2021-05-06 | $513.88M derived: sum of 3 quarters · filed 2021-11-04 | $532.83M derived: sum of 4 quarters · filed 2021-11-04 |
| 2020-12-31 | $9.00M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25 | $510.19M derived: sum of 2 quarters · filed 2021-11-04 | $529.13M derived: sum of 3 quarters · filed 2021-11-04 | $538.01M 10-K · filed 2021-02-25 |
| 2020-09-30 | $501.19M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04 | $520.14M derived: sum of 2 quarters · filed 2021-11-04 | $529.01M 10-Q · filed 2021-11-04 | $531.68M derived: sum of 4 quarters · filed 2021-11-04 |
| 2020-06-30 | $18.95M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-05 | $27.82M 10-Q · filed 2021-08-05 | $30.49M derived: sum of 3 quarters · filed 2021-08-05 | $35.49M derived: sum of 4 quarters · filed 2021-08-05 |
| 2020-03-31 | $8.87M 10-Q · filed 2021-05-06 | $11.55M derived: sum of 2 quarters · filed 2021-05-06 | $16.54M derived: sum of 3 quarters · filed 2021-05-06 | $18.28M derived: sum of 4 quarters · filed 2021-05-06 |
| 2019-12-31 | $2.67M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25 | $7.67M derived: sum of 2 quarters · filed 2021-02-25 | $9.40M derived: sum of 3 quarters · filed 2021-02-25 | $258.72M 10-K · filed 2021-02-25 |
| 2019-09-30 | $5.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | $6.73M derived: sum of 2 quarters · filed 2020-11-05 | $256.05M 10-Q · filed 2020-11-05 | $256.93M derived: sum of 4 quarters · filed 2021-02-25 |
| 2019-06-30 | $1.73M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-06 | $251.05M 10-Q · filed 2020-08-06 | $251.94M derived: sum of 3 quarters · filed 2021-02-25 | $260.23M derived: sum of 4 quarters · filed 2021-02-25 |
| 2019-03-31 | $249.32M 10-Q · filed 2020-05-11 | $250.20M derived: sum of 2 quarters · filed 2021-02-25 | $258.50M derived: sum of 3 quarters · filed 2021-02-25 | $260.52M derived: sum of 4 quarters · filed 2021-02-25 |
| 2018-12-31 | $886.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25 | $9.18M derived: sum of 2 quarters · filed 2021-02-25 | $11.21M derived: sum of 3 quarters · filed 2021-02-25 | $16.15M 10-K · filed 2021-02-25 |
| 2018-09-30 | $8.30M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-06 | $10.32M derived: sum of 2 quarters · filed 2019-11-06 | $15.26M 10-Q · filed 2019-11-06 | $43.74M derived: sum of 4 quarters · filed 2020-02-27 |
| 2018-06-30 | $2.02M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-05 | $6.96M 10-Q · filed 2019-08-05 | $35.44M derived: sum of 3 quarters · filed 2020-02-27 | $225.49M derived: sum of 4 quarters · filed 2020-02-27 |
| 2018-03-31 | $4.94M 10-Q · filed 2019-05-09 | $33.41M derived: sum of 2 quarters · filed 2020-02-27 | $223.47M derived: sum of 3 quarters · filed 2020-02-27 | $223.71M derived: sum of 4 quarters · filed 2020-02-27 |
| 2017-12-31 | $28.48M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-27 | $218.53M derived: sum of 2 quarters · filed 2020-02-27 | $218.78M derived: sum of 3 quarters · filed 2020-02-27 | $220.30M 10-K · filed 2020-02-27 |
| 2017-09-30 | $190.05M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-10-30 | $190.30M derived: sum of 2 quarters · filed 2018-10-30 | $191.82M 10-Q · filed 2018-10-30 | $193.61M derived: sum of 4 quarters · filed 2019-02-27 |
| 2017-06-30 | $247.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-02 | $1.77M 10-Q · filed 2018-08-02 | $3.56M derived: sum of 3 quarters · filed 2019-02-27 | $6.11M derived: sum of 4 quarters · filed 2019-02-27 |
| 2017-03-31 | $1.52M 10-Q · filed 2018-05-08 | $3.31M derived: sum of 2 quarters · filed 2019-02-27 | $5.86M derived: sum of 3 quarters · filed 2019-02-27 | $6.31M derived: sum of 4 quarters · filed 2019-02-27 |
| 2016-12-31 | $1.79M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-27 | $4.34M derived: sum of 2 quarters · filed 2019-02-27 | $4.79M derived: sum of 3 quarters · filed 2019-02-27 | $146.67M 10-K · filed 2019-02-27 |
| 2016-09-30 | $2.55M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-07 | $3.00M derived: sum of 2 quarters · filed 2017-11-07 | $144.88M 10-Q · filed 2017-11-07 | $145.81M derived: sum of 4 quarters · filed 2018-02-27 |
| 2016-06-30 | $449.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-03 | $142.32M 10-Q · filed 2017-08-03 | $143.25M derived: sum of 3 quarters · filed 2018-02-27 | $144.39M derived: sum of 4 quarters · filed 2018-02-27 |
| 2016-03-31 | $141.88M 10-Q · filed 2017-05-08 | $142.80M derived: sum of 2 quarters · filed 2018-02-27 | $143.94M derived: sum of 3 quarters · filed 2018-02-27 | $144.83M derived: sum of 4 quarters · filed 2018-02-27 |
| 2015-12-31 | $928.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-27 | $2.07M derived: sum of 2 quarters · filed 2018-02-27 | $2.95M derived: sum of 3 quarters · filed 2018-02-27 | $4.50M 10-K · filed 2018-02-27 |
| 2015-09-30 | $1.14M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-03 | $2.02M derived: sum of 2 quarters · filed 2016-11-03 | $3.58M 10-Q · filed 2016-11-03 | |
| 2015-06-30 | $884.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-04 | $2.44M 10-Q · filed 2016-08-04 | ||
| 2015-03-31 | $1.55M 10-Q · filed 2016-05-05 | |||
| 2014-12-31 | $117.03M 10-K · filed 2017-03-01 | |||
| 2013-12-31 | $93.51M 10-K · filed 2016-02-25 |